NCT02182037View on ClinicalTrials.gov

Safety, Pharmacodynamics, and Pharmacokinetics of BIBT 1011 BS in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

August 31, 2001

Primary Completion Date

September 30, 2001

Conditions
Healthy
Interventions
DRUG

Single rising doses of BIBT 1011 BS

DRUG

BIBT 1011 BS placebo

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY